On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Jeff Hargroves has agreed to resign from the Board as a Class I director solely for the purpose of being re-appointed to the Board as a Class II director.
On May 15, 2026, Wayne A. Stevens notified the Boards of Directors of Trustmark Corporation (the "Company") and its wholly owned subsidiary, Trustmark Bank (the “Bank”), of his intention to retire as President - Retail Banking of the Bank, effective as of July 3, 2026.
On May 13, 2026, Shirley A. Rozeboom, Vice President – Stauber, was determined to no longer be an “executive officer” of Hawkins, Inc. (the “Company”), effective as of the same date.
On May 14, 2026, Core Molding Technologies, Inc. (the “ Company ”) and David L. Duvall the Company’s President and Chief Executive Officer entered into a Transition Agreement (the “ Transition Agreement ”), in connection with the previously announced planned transition and retirement of Mr. Duvall.
On May 18, 2026 (the “ Effective Date ”), Vistagen Therapeutics, Inc. (the “ Company ”) appointed Angel S. Angelov, M.D., MBA to serve as the Company’s Chief Medical Officer.
Departed
Charles T. Lauber
Executive Vice President and Chief Financial Officer
On May 19, 2026, A. O. Smith Corporation (the “Company") disclosed that it has selected Carrie Anderson as its Executive Vice President and Chief Financial Officer effective July 1, 2026.
On May 19, 2026, Sprouts Farmers Market, Inc. (the “Company”) announced the appointment of Andrew Jhawar to its Board of Directors (the “Board”) as a Class III director with a term expiring at the Company’s 2028 annual meeting of stockholders.
Richard H. Raborn, the Executive Vice President of the Vegetation Management Division of Alamo Group Inc. (the “Company”), will be retiring from the Company on May 29, 2026.
On May 19, 2026, First Merchants Corporation (the “Corporation”) announced the retirement of Gary Lehman from the Board of Directors effective immediately.
Departed
Peter H. Griffith
Executive Vice President and Chief Financial Officer
On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.
Appointed
Thomas Dittrich
Executive Vice President and Chief Financial Officer
On May 15, 2026, David B. Mitchell, II, Chief Wholesale Banking Officer of F.N.B. Corporation (the “Company”), announced his intention to retire from the Company effective July 2, 2026.
Appointed
Amber Scott
Chief Accounting Officer and Principal Accounting Officer
On May 18, 2026, the board of directors of EVgo Inc. (the “Company”) appointed Amber Scott as the Company's Chief Accounting Officer and Principal Accounting Officer, effective May 18, 2026.
on May 18, 2026, the Boards appointed Mr. Iafigliola as the President and Chief Executive Officer of the Company and the Bank, effective as of May 18, 2026
On May 19, 2026, A. Lee Finley resigned from his position as a member of the Board of Directors of GBank Financial Holdings Inc. effective immediately.
On May 15, 2026, the board of directors (the “Board”) of GBank Financial Holdings Inc. (the “Company”) and the board of directors of the Company’s wholly owned bank subsidiary, GBank (“GBank”), approved the appointment of Jeff Newgard as President and Chief Executive Officer of GBank, effective June 8, 2026.
On May 18, 2026, Zhe Zhang, a member of the Board of Directors (the “Board”) and the audit committee of Valuence Merger Corp. I (the “Company”), resigned from the Board, effective immediately.
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
On May 19, 2026, the board of directors (the “Board”) of Rogers Corporation (the “Company”) appointed Ali El-Haj, currently the Company’s Interim President and Chief Executive Officer, to the positions of President and Chief Executive Officer and as a member of the Board, effective immediately.
On May 19, 2026, the board of directors (the “Board”) of Rogers Corporation (the “Company”) appointed Ali El-Haj, currently the Company’s Interim President and Chief Executive Officer, to the positions of President and Chief Executive Officer and as a member of the Board, effective immediately.
On May 16, 2026, TOMI Environmental Solutions, Inc. (the “Company”) appointed Mr. Niroshan Srirathan as the Company’s Interim Chief Financial Officer, effective immediately.
On May 19, 2026, Upstart Holdings, Inc. (“Upstart” or the “Company”) announced that its Board of Directors (the “Board”) elected Tim Wennes to serve as a Class I director on the Board, effective as of May 28, 2026.
On May 19 , 2026, Jeff Huber informed the Company that he will resign from the Board and the Nominating and Corporate Governance Committee of the Board, effective as of May 28, 2026.
On May 18, 2026, Robert E. James, Jr. retired as a director of HomeTrust Bancshares, Inc. (the "Company"), the holding company for HomeTrust Bank (the "Bank"), effective at the completion of the Company's annual meeting of stockholders held that day (the "Annual Meeting").
On May 18, 2026, Diego Miralles, M.D. resigned as a member of the Board of Directors (the “Board”) of Artiva Biotherapeutics, Inc. (the “Company”), effective May 18, 2026
Role change
Fred Aslan
principal financial officer and principal accounting officer
On May 18, 2026 (the “Effective Date”), Fred Aslan, M.D. resigned as President of the Company in connection with Dr. Miralles’s appointment as President and Head of Research and Development of the Company as described below.
On May 18, 2026, Thad Huston and the Company agreed to Mr. Huston’s separation from his position as Chief Financial Officer and principal financial and accounting officer of the Company, effective May 22, 2026
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.